← Back
$CNTA All transactions

Centessa Pharmaceuticals plc

▼ SELL 10b5-1 Plan

$ Value

$127K

Shares

8,322

Price

$15

Filed

Jul 30

Insider

Name

Accardi Mario Alberto

Title

President, Orexin Program

CIK

0002074392

Roles

Officer

Transaction Details

Transaction Date

2025-07-29

Code

S

Table

Non-Derivative

Ownership

Direct

Equity Swap

No

Shares After

208,163

Footnotes

The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share. | The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on February 14, 2025. | The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $15.105 to $15.41, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.

Filing Info

Accession No.

0001847903-25-000125

Form Type

4

Issuer CIK

0001847903

Accardi Mario Alberto's History

Date Ticker Type Value
2026-02-02 CNTA A $0
2026-02-02 CNTA A $0
2026-02-01 CNTA F $72K
2025-12-09 CNTA $213K
2025-12-09 CNTA $75K
2025-12-08 CNTA M $48K
2025-12-08 CNTA $300K
2025-12-08 CNTA M $0
2025-11-01 CNTA F $15K
2025-10-27 CNTA M $40K

Other Insiders at CNTA (90d)

Insider Bought Sold Last
Weinhoff Gregory M
Chief Business Officer
$2.6M 2026-03-26
Crowley John J
Chief Financial Officer
2026-02-02
Kanes Stephen
Chief Medical Officer
2026-02-02
Anderson Karen M.
Chief People Officer
$6.5M 2026-03-26
HUSSAIN IQBAL J
Chief Legal Officer
$1.0M 2026-02-02
Bush Tia L
Chief Technology & Quality Ofc
2026-02-02
Deferiere Raphael
Chief Accounting Officer
2026-02-02
Accardi Mario Alberto
Chief Executive Officer
2026-02-02